4//SEC Filing
VIDA JULIUS A 4
Accession 0001179110-06-024246
CIK 0000874255other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:46 PM ET
Size
10.0 KB
Accession
0001179110-06-024246
Insider Transaction Report
Form 4
MEDAREX INCMEDX
VIDA JULIUS A
Director
Transactions
- Disposition to Issuer
Stock Option(Right to Buy)
2006-12-21−32,000→ 0 totalExercise: $45.20Exp: 2000-10-12→ Common Stock (32,000 underlying) - Award
Stock Option (Right to Buy)
2006-12-21+32,000→ 32,000 totalExercise: $64.57Exp: 2000-10-12→ Common Stock (32,000 underlying)
Footnotes (4)
- [F1]The reporting person has entered into an agreement, dated December 21, 2006 (the "Agreement"), with Medarex, Inc. (the "Company") to amend the exercise prices of that number of unexercised shares subject to each option as reported in this Form 4 (each, a "Subject Option") to increase the exercise price to 100% of the fair market value of the Company's common stock on the applicable accounting measurement date for each Subject Option, as such applicable accounting measurement date has been revised by the Company for purposes of the Company's restated financial statements (continue to Footnote 2).
- [F2]The exercise prices reported in this Form 4 are subject to further adjustment based on additional revisions required by the Company in connection with the Company's auditors' review of the Company's restated financial statements. If any further adjustments to the applicable accounting measurement dates or to the applicable exercise prices are required as a result of the auditors' review of the Company's restated financial statements, this reporting person will file an amendment to this Form 4 to reflect the exercise prices as further amended. See the Company's Report on Form 8-K that will be filed with the Securities and Exchange Commission for additional information (continue to Footnote 3).
- [F3]For Section 16 reporting purposes only, the increase in option exercise price is deemed to be a cancellation of the old option and the grant of a replacement option. The other terms of the outstanding Subject Options (including any vesting of the Subject Options) remain unchanged; provided, however, that the Subject Options may not generally be exercised as to those shares that vested after December 31, 2004 prior to the six month anniversary of the date of the Agreement. See the Company's Report on Form 8-K filed with the Securities and Exchange Commission for additional information.
- [F4]The original option grant date was October 13, 2000 and the revised accounting measurement date is October 24, 2000.
Documents
Issuer
MEDAREX INC
CIK 0000874255
Entity typeother
Related Parties
1- filerCIK 0001214509
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 5:46 PM ET
- Size
- 10.0 KB